Mednet Logo

What is your recommended sequence of therapies for achieving optimal proteinuria reduction in IgA nephropathy, especially in light of the recent approvals of sparsentan, delayed-release budesonide, and iptacopan?

Do you recommend starting iptacopan or budesonide concurrently with ACE inhibitors/ARBs or sparsentan, or do you prefer a period of monitoring before adding these targeted medications?
Community PollStarted

What is your recommended sequence of therapies for achieving optimal proteinuria reduction in IgA nephropathy?

109 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet Member
Nephrology · University of Chicago Medicine
Answered on · Updated on

I am actually quite persistent with conservative therapies first - I push an ARB or ACE inhibitor in an effort to get the proteinuria under 1 gram per day, or ideally 0.75 gram per day. I favor stronger ARBs such as olmesartan or azilsartan over weaker ones such as losartan or valsartan, and really ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Nephrology · University of Wisconsin School of Medicine and Public Health
Answered on

When approaching treatment for a new diagnosis of IgAN, it is important to look at the presentation and the biopsy findings before considering treatment. If the patient has the classical presentation of proteinuria with hematuria (with/without low GFR) and kidney biopsy with mesangial hypercellulari...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Nephrology · NewYork-Presbyterian / Columbia University Irving Medical Center
Answered on · Updated on

This question depends a great deal on the patient's trajectory and clinical features. I always start with ACEI or ARB, and uptitrate as rapidly as tolerated. I then add an SGLT2i, though I may delay this if we plan to add immunosuppression. In a patient with aggressive/active disease (based on biops...

Join for free or sign in to see the full answer